Royal Papworth Hospital NHS Foundation Trust

What Royal Papworth Hospital NHS Foundation Trust does

Royal Papworth Hospital NHS Foundation Trust is a public NHS Foundation Trust and the UK's leading specialist heart and lung hospital, headquartered on the Cambridge Biomedical Campus in Cambridge. Founded in 1918 as a tuberculosis settlement colony, the Trust has evolved over more than a century into a tertiary and quaternary cardiothoracic centre treating over 50,000 patients and delivering 130,000+ episodes of care annually. It performs more heart, heart-lung and lung transplants each year than any other UK hospital and operates the UK's only pulmonary endarterectomy service, one of five UK ECMO centres, and the country's largest Respiratory Support and Sleep Centre. The Trust was granted Royal status in 2017, was rated Outstanding across all five CQC domains in October 2019 (the first NHS Trust to achieve a clean sweep), and relocated to a new state-of-the-art hospital in May 2019.

Its clinical portfolio is organised around five pillars: Cardiology (cardiac assessment, coronary artery disease, heart rhythm disturbances, structural heart disease and heart failure); Respiratory Services (Cambridge Centre for Lung Infection, Interstitial Lung Disease, lung cancer, Pulmonary Vascular Diseases Unit, Respiratory Support and Sleep Centre, and Respiratory Physiology); Surgery (cardiac, thoracic, transplant and the UK's only pulmonary endarterectomy service); Theatres, Critical Care and Anaesthetics (including ECMO); and Support Services. It also runs an Adult Cystic Fibrosis Centre and Private Care services for self-paying and insured UK and international patients. A notable Research & Development function is anchored by the Heart and Lung Research Institute, a 2022 joint venture with the University of Cambridge, alongside a Clinical Research Facility, Papworth Trials Unit Collaboration and tissue bank. Distinguishing technical capabilities include the world's largest DCD heart transplant programme (Europe's first in 2015, 100th procedure in 2022), the world's first paediatric DCD heart transplant programme (2020 with Great Ormond Street Hospital), and the UK's first deployment of a new-generation thoracic surgery robot in spring 2023.

The Trust's revenue model is dominated by NHS England and Clinical Commissioning Group commissioning for specialist cardiothoracic services under nationally mandated tariffs, supplemented by private patient income on a fee-for-service basis and charitable donations via Royal Papworth Charity and NHS Charities Together. Distribution runs through the national NHS referral pathway (primary catchment East of England, national reach for transplantation, PTE and ECMO), supplemented by regional outreach clinics and direct private care channels.

Name

Royal Papworth Hospital NHS Foundation Trust

Legal name

Royal Papworth Hospital NHS Foundation Trust

Website

https://royalpapworth.nhs.uk

Company type

Public

Founded year

1918

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Royal Papworth Hospital NHS Foundation Trust is the UK's leading specialist heart and lung NHS Foundation Trust, delivering tertiary cardiothoracic care — including transplantation, ECMO and pulmonary endarterectomy — to over 50,000 patients annually across the East of England and nationally.

Ownership category

akta.pro rank

Product category

Specialist Cardiothoracic Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060)

akta.pro primary industry

Cardiac & Cardiothoracic Specialty Hospitals (HLAFAHAA)

akta.pro secondary industry

Palliative Care, Hospice & Serious Illness Support (BPAGACAK)

Keywords

• Cardiothoracic surgery
• Heart transplantation
• Lung transplantation
• Specialist hospital services
• Respiratory medicine

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Others

Revenue model

1. NHS Clinical Services: Core revenue from NHS England and Clinical Commissioning Groups for specialist cardiothoracic services, transplants, and tertiary care. Funded through the NHS payment system based on activity and nationally mandated tariffs.
2. Private Patient Services: Private healthcare services for self-paying and insured patients from the UK and internationally, providing cardiac and respiratory treatments in dedicated private care facilities.
3. Charitable Donations: Royal Papworth Charity receives donations to support equipment, research, and enhanced patient care beyond NHS provision. Received £520,000 in donations and £183,000 in item donations during the COVID-19 pandemic.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Core offering

Royal Papworth Hospital NHS Foundation Trust is a specialist heart and lung hospital located in Cambridge, UK, providing tertiary cardiothoracic services including cardiothoracic surgery, heart and lung transplantation, respiratory medicine, and critical care. The Trust serves over 50,000 patients per year across 130,000 episodes of care, operating as one of the UK's leading specialist centres and a pioneer in advanced cardiac and respiratory treatments.

Product overview

Royal Papworth Hospital NHS Foundation Trust operates as the UK's leading heart and lung specialist hospital, delivering over 130,000 patient episodes annually. The organization offers a comprehensive portfolio of core clinical services organized around five main pillars: Cardiology Services (cardiac assessment, coronary disease, heart rhythm, structural heart disease, heart failure), Respiratory Services (lung infection, ILD, lung cancer, PVDU, RSSC, respiratory physiology), Surgery (cardiac surgery, thoracic surgery, transplant services, pulmonary endarterectomy), Theatres/Critical Care/Anaesthetics (including ECMO), and Support Services (rehabilitation, chaplaincy, nutrition, pharmacy, radiology, physiotherapy). The hospital also operates a dedicated Adult Cystic Fibrosis Centre and provides Private Care services. Research and Development is a significant component, featuring the Heart and Lung Research Institute (HLRI) in partnership with the University of Cambridge, a Clinical Research Facility, Papworth Trials Unit Collaboration, and a tissue bank. The hospital offers virtual care through video consultations. All services are provided from a state-of-the-art facility on the Cambridge Biomedical Campus, with outreach clinics across the East of England.

Differentiator

Problem solved

Functional benefit

Brands

• Royal Papworth Charity: The hospital's affiliated charity that supports the work of Royal Papworth Hospital through fundraising and donations.

Products and services

• Cardiology Services
• Respiratory Medicine
• Cardiothoracic Surgery
• Heart and Lung Transplantation
• Theatres, Critical Care and Anaesthetics
• Private Care Services

Quantifiable outcome

• Performs more heart, heart-lung and lung transplants each year than any other UK centre
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Seven partnerships are on record, tiered flagship, core and supporting.

• University of CambridgeflagshipStrategic or Co-development Partner · 1 January 2022Joint venture to establish Heart and Lung Research Institute on Cambridge Biomedical Campus, creating largest cardiothoracic centre for research, education, industry collaboration and clinical care in Europe. Institute opened in July 2022.
• Great Ormond Street Hospital for Children (GOSH)flagshipStrategic or Co-development Partner · 1 January 2020Collaboration on world-first pediatric heart transplant programme using DCD technique, offering life-saving transplants to six young patients in 2020.
• Cambridge University Health Partners (CUHP)coreStrategic or Co-development PartnerPartnership between University of Cambridge and three NHS Foundation Trusts (Royal Papworth, Cambridge University Hospitals, and Cambridgeshire and Peterborough NHS Foundation Trust). Delivers world-class excellence in healthcare, research, clinical education and improves health of people across Cambridgeshire, East of England and nationally.
• NHS Trusts (regional partners)coreStrategic or Co-development PartnerPartnerships with NHS trusts across the East of England for patient referrals, shared care, and regional healthcare delivery.
• NHS EnglandcoreStrategic or Co-development PartnerNational commissioning relationship for specialist services including transplantation, ECMO, and pulmonary endarterectomy.
• NHS Charities TogethersupportingOthersReceived £520,000 in donations and £183,000 in item donations through NHS Charities Together partnership during the COVID-19 pandemic.
• Cancer Research UKsupportingStrategic or Co-development PartnerCollaboration on lung cancer urine test research for early detection, working with the University of Cambridge and the hospital's tissue bank.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Royal Brompton Hospital (Guy's and St Thomas' NHS Foundation Trust): Royal Brompton is the UK's other flagship specialist heart and lung hospital, merged into Guy's and St Thomas' in 2021. It runs a directly comparable portfolio of complex cardiac surgery, transplantation, respiratory medicine and ECMO, competing for national specialist referrals, transplant activity and clinical talent.
• Liverpool Heart and Chest Hospital NHS Foundation Trust: A standalone specialist cardiothoracic NHS trust providing cardiac surgery, thoracic surgery, transcatheter interventions and transplantation across the North West. Directly comparable specialist model and patient mix, competing for UK-wide referrals and clinical talent.
• Barts Heart Centre (Barts Health NHS Trust): Europe's largest specialist cardiac centre, delivering high-volume interventional cardiology, cardiac surgery and structural heart services within a larger acute trust. Overlaps Royal Papworth on cardiology, structural heart and arrhythmia services for a shared national patient pool.
• Freeman Hospital (Newcastle upon Tyne Hospitals NHS Foundation Trust): Major UK cardiothoracic centre performing heart and lung transplantation, complex cardiac surgery and ECMO for the North East and national referrals. Competes directly with Royal Papworth for transplant capacity and specialist surgical reputation.
• Hammersmith Hospital (Imperial College Healthcare NHS Trust): Major London tertiary centre with significant cardiology, cardiac surgery and heart failure services closely linked to Imperial College London's research base. Comparable specialist cardiac offering and academic partnership model for transplant and advanced heart failure referrals.
• University Hospitals Birmingham NHS Foundation Trust: Large teaching trust operating a major cardiac surgery and cardiology centre. Comparable in delivering high-volume complex cardiac care to a national patient pool, particularly for transplantation and structural heart intervention.
• Royal Brompton Harefield (post-merger combined entity): Combined Royal Brompton and Harefield sites under Guy's and St Thomas', providing heart and lung transplantation, ECMO and respiratory medicine alongside Royal Papworth's offerings. Direct competitor for NHS England specialist commissioning and clinical staff.

Regional players

• Golden Jubilee University National Hospital (NHS Golden Jubilee): Scottish national hospital for cardiac surgery, thoracic surgery and heart transplantation. Comparable in specialist scope but focused on Scottish regional catchment, making it a regional peer rather than a direct East of England competitor.

Broad incumbents

• Cleveland Clinic: US-based academic medical centre with a large heart, vascular and thoracic institute delivering high-volume transplantation, structural heart and robotic surgery. Comparable as a global specialty benchmark for clinical outcomes, research output and international patient services rather than a direct NHS competitor.
• Mayo Clinic: US-based integrated specialty provider with renowned cardiovascular and transplant programmes and an integrated research arm. Comparable in scale and reputation as a specialty referral centre, and a relevant benchmark for clinical-research integration rather than a direct UK competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCLtEt-gv2xNUEBYYKcFCalg
• Facebookfacebook.com/RoyalPapworth
• LinkedInlinkedin.com/company/royal-papworth-hospital-nhs-foundation-trust
• Instagraminstagram.com/royalpapworth
• Xx.com/royalpapworth

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Royal Papworth Hospital NHS Foundation Trust